MDL-800

Overview
Catalog #	bs-82860c-10-mg
Product Name	MDL-800
Specifications
Storage Buffer	Off-white/beige solid
Storage Condition	-20°C
Target
Product Information	Allosteric activator of SIRT6 (EC50 = 10.3 µM).1 It specifically activates the deacetylase (H3K9ac and H3K56ac) activity of SIRT6 – inactive against SIRT1,3,4 and HDACs 1-11 with 10x less activity against SIRT2,5,7. It inhibited the growth of human hepatocarcinoma cells (HCC) via the tumor suppressor deacetylase (H3K9ac and H3K56ac) via cell-cycle arrest and showed efficacy in a xenograft model of HCC. MDL-800 improved the genetic stability of old-murine-derived iPSCs via activation of NHEJ and BER DNA repair pathways suggesting promise in treating age-related diseases via iPSC-based therapies.2 MDL-800 inhibited the proliferation of 12 non-small cell lung carcinoma cell lines with IC50 values of 21.5 to 34.5 µM.3 It also enhanced the effects of EGFR kinase inhibitors in Osimertinib-resistant HCC827 and PC9 cells as well as in patient-derived primary tumor cells.3
Description	CAS Number: 2275619-53-7 Chemical Name: Methyl 2-(N-(5-Bromo-4-fluoro-2-methylphenyl)sulfamoyl)-5-(3,5-dichlorophenylsulfonamido)benzoate Molecular weight: 626.29 Formula: C21H16BrCl2FN2O6S2 Solubility: DMSO (up to at least 10 mg/ml with warming) Physical Properties: White solid Purity: 98% by HPLC NMR (Conforms)